These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23953189)

  • 1. Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor.
    McClure KF; Jackson M; Cameron KO; Kung DW; Perry DA; Orr ST; Zhang Y; Kohrt J; Tu M; Gao H; Fernando D; Jones R; Erasga N; Wang G; Polivkova J; Jiao W; Swartz R; Ueno H; Bhattacharya SK; Stock IA; Varma S; Bagdasarian V; Perez S; Kelly-Sullivan D; Wang R; Kong J; Cornelius P; Michael L; Lee E; Janssen A; Steyn SJ; Lapham K; Goosen T
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5410-4. PubMed ID: 23953189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.
    Kung DW; Coffey SB; Jones RM; Cabral S; Jiao W; Fichtner M; Carpino PA; Rose CR; Hank RF; Lopaze MG; Swartz R; Chen HT; Hendsch Z; Posner B; Wielis CF; Manning B; Dubins J; Stock IA; Varma S; Campbell M; DeBartola D; Kosa-Maines R; Steyn SJ; McClure KF
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4281-7. PubMed ID: 22677316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists.
    McCoull W; Barton P; Brown AJ; Bowker SS; Cameron J; Clarke DS; Davies RD; Dossetter AG; Ertan A; Fenwick M; Green C; Holmes JL; Martin N; Masters D; Moore JE; Newcombe NJ; Newton C; Pointon H; Robb GR; Sheldon C; Stokes S; Morgan D
    J Med Chem; 2014 Jul; 57(14):6128-40. PubMed ID: 24967667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, evaluation, and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging.
    Chollet C; Bergmann R; Pietzsch J; Beck-Sickinger AG
    Bioconjug Chem; 2012 Apr; 23(4):771-84. PubMed ID: 22372770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.
    Pasternak A; Goble SD; deJesus RK; Hreniuk DL; Chung CC; Tota MR; Mazur P; Feighner SD; Howard AD; Mills SG; Yang L
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6237-40. PubMed ID: 19767208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.
    Kong J; Chuddy J; Stock IA; Loria PM; Straub SV; Vage C; Cameron KO; Bhattacharya SK; Lapham K; McClure KF; Zhang Y; Jackson VM
    Br J Pharmacol; 2016 May; 173(9):1452-64. PubMed ID: 26784385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin receptor modulators: a patent review (2011 - 2014).
    Costantino L; Barlocco D
    Expert Opin Ther Pat; 2014 Sep; 24(9):1007-19. PubMed ID: 25047815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor.
    Els S; Schild E; Petersen PS; Kilian TM; Mokrosinski J; Frimurer TM; Chollet C; Schwartz TW; Holst B; Beck-Sickinger AG
    J Med Chem; 2012 Sep; 55(17):7437-49. PubMed ID: 22920150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists.
    Wang L; Hubert JA; Lee SJ; Pan J; Qian S; Reitman ML; Strack AM; Weingarth DT; MacNeil DJ; Weber AE; Edmondson SD
    Bioorg Med Chem Lett; 2011 May; 21(10):2911-5. PubMed ID: 21493064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminus of a hexapeptidic ghrelin receptor inverse agonist can switch peptide behavior from inverse agonism to agonism.
    Els-Heindl S; Bellmann-Sickert K; Beck-Sickinger AG
    Biopolymers; 2016 Jan; 106(1):101-8. PubMed ID: 26566778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists.
    Gardelli C; Wada H; Ray A; Caffrey M; Llinas A; Shamovsky I; Tholander J; Larsson J; Sivars U; Hultin L; Andersson U; Sanganee HJ; Stenvall K; Leidvik B; Gedda K; Jinton L; Rydén Landergren M; Karabelas K
    J Med Chem; 2018 Jul; 61(14):5974-5987. PubMed ID: 29909635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.
    Takle AK; Bamford MJ; Davies S; Davis RP; Dean DK; Gaiba A; Irving EA; King FD; Naylor A; Parr CA; Ray AM; Reith AD; Smith BB; Staton PC; Steadman JG; Stean TO; Wilson DM
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4373-6. PubMed ID: 18621524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptor.
    Takahashi B; Funami H; Iwaki T; Maruoka H; Nagahira A; Koyama M; Kamiide Y; Matsuo T; Muto T; Annoura H
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2707-12. PubMed ID: 25981690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist.
    Salomé N; Hansson C; Taube M; Gustafsson-Ericson L; Egecioglu E; Karlsson-Lindahl L; Fehrentz JA; Martinez J; Perrissoud D; Dickson SL
    J Neuroendocrinol; 2009 Sep; 21(9):777-85. PubMed ID: 19703102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
    Els S; Beck-Sickinger AG; Chollet C
    Methods Enzymol; 2010; 485():103-21. PubMed ID: 21050913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.
    Mahalingam AK; Wan Y; Murugaiah AM; Wallinder C; Wu X; Plouffe B; Botros M; Nyberg F; Hallberg A; Gallo-Payet N; Alterman M
    Bioorg Med Chem; 2010 Jun; 18(12):4570-90. PubMed ID: 20493713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent MCH-1 receptor antagonists from cis-1,4-diaminocyclohexane-derived indane analogs.
    Qian Y; Conde-Knape K; Erickson SD; Falcioni F; Gillespie P; Hakimi I; Mennona F; Ren Y; Salari H; So SS; Tilley JW
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4216-20. PubMed ID: 23743277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Piperidin-4-ylidenemethyl-benzamides as δ-opioid receptor agonists for CNS indications: identifying clinical candidates.
    Dantzman CL; King MM; Ernst GE; Wang X; McCauley JP; Andisik DW; Brush K; Bui KH; Frietze W; Hoesch V; Liu J; Palmer WE; Spear N; Hudzik TJ; Wesolowski SS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1174-8. PubMed ID: 22197137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 2-imidazoles as potent, selective and CNS penetrant alpha1A adrenoceptor partial agonists.
    Roberts LR; Bryans J; Conlon K; McMurray G; Stobie A; Whitlock GA
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6437-40. PubMed ID: 18980842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.